Saturday, August 15, 2026

HLB’s Liraglutide: A Game-Changer in Cholangiocarcinoma Treatment with FDA Priority Review

HLB's Elevar Therapeutics receives FDA Priority Review for lirafugratinib, a promising treatment for cholangiocarcinoma with a 47% response rate.

Apple’s Foldable iPhone: What to Expect from the September 2026 Launch

Samsung's Galaxy Z8 foldable series sells out in pre-orders, while Apple's foldable product is expected to launch in September.

PYONGYANG’S BIG LIE: Free Medicine Is Now A ‘Great Devotion’ When Citizens Are Starving

North Korea's Rodong Sinmun promotes patriotism, unity, and socialist values, highlighting Kim Jong Un's humanitarian policies and health initiatives.

Tag: antifungal resistance

New Class 4 Disease Regulations on Candida Auris Starting March 29 in South Korea

KDCA classifies Candida auris as a Class 4 infectious disease, enhancing surveillance and management to combat this resistant pathogen.

Top News

How Mythos Shock AI Models Are Transforming Cybersecurity: What You Need...

Yun Jun Na - April 23, 2026

The government is negotiating with Anthropic and OpenAI to tackle cyber threats from advanced AI models like Mythos, emphasizing security collaboration.